Efficacy of efruxifermin in improving liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis/nonalcoholic steatohepatitis: a systematic review and meta-analysis of randomized controlled trials.
- DOI
- 10.1097/meg.0000000000003259
- Published
- 2026 Aug 5
- Container
- European journal of gastroenterology & hepatology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1097/meg.0000000000003259,
title = {Efficacy of efruxifermin in improving liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis/nonalcoholic steatohepatitis: a systematic review and meta-analysis of randomized controlled trials.},
author = {Abideen ZU and Waseem MH and Shoaib A and Osama M and Fatima T and Panjwani MH and Ramzan NU and Thada PK and Jalal PK},
year = {2026},
journal = {European journal of gastroenterology \& hepatology},
doi = {10.1097/meg.0000000000003259},
url = {https://doi.org/10.1097/meg.0000000000003259}
}RIS
TY - JOUR TI - Efficacy of efruxifermin in improving liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis/nonalcoholic steatohepatitis: a systematic review and meta-analysis of randomized controlled trials. AU - Abideen ZU AU - Waseem MH AU - Shoaib A AU - Osama M AU - Fatima T AU - Panjwani MH AU - Ramzan NU AU - Thada PK AU - Jalal PK PY - 2026 JO - European journal of gastroenterology & hepatology DO - 10.1097/meg.0000000000003259 UR - https://doi.org/10.1097/meg.0000000000003259 ER -
APA
ZU, A., MH, W., A, S., M, O., T, F., MH, P., NU, R., PK, T., & PK, J. (2026). Efficacy of efruxifermin in improving liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis/nonalcoholic steatohepatitis: a systematic review and meta-analysis of randomized controlled trials.. European journal of gastroenterology & hepatology. https://doi.org/10.1097/meg.0000000000003259
Source records
- pubmed · retrieved 2026-09-26T04:51:31.713Z